Dufek MB

No ORCID on file · 2 papers in corpus
article 2020
Journal of clinical pharmacology ·doi:10.1002/jcph.1689

Elagolix is an oral gonadotropin-releasing hormone receptor antagonist indicated for the management of endometriosis-associated pain and in combination with estradiol/norethindrone acetate indicated for the management of heavy menstrual ble…

2018
Obstetrics and gynecology ·doi:10.1097/aog.0000000000002933

ObjectiveTo evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyoma…